Story perspectives

Glyphosate Study Retraction Sparks Safety Debate in Agriculture

1/4/2026

Summary

Story summary

The retraction of a pivotal 2000 glyphosate study reignites safety debates in American agriculture.
Regulatory Toxicology and Pharmacology cited ethical concerns about undisclosed ties to Monsanto shaping the study.
Dr. Philip J. Landrigan argues the retraction exposes a long-standing industry narrative on glyphosate's safety.
The MAHA Commission's May 2025 report calls for ongoing scientific review, and the Environmental Protection Agency (EPA) plans a 2026 safety assessment.

1 of 1

Story summary

The retraction of a pivotal 2000 glyphosate study reignites safety debates in American agriculture.
Regulatory Toxicology and Pharmacology cited ethical concerns about undisclosed ties to Monsanto shaping the study.
Dr. Philip J. Landrigan argues the retraction exposes a long-standing industry narrative on glyphosate's safety.
The MAHA Commission's May 2025 report calls for ongoing scientific review, and the Environmental Protection Agency (EPA) plans a 2026 safety assessment.